Boston Scientific (BSX) Construction in Progress (2009 - 2026)
Boston Scientific's (BSX) quarterly Construction in Progress came in at $1.1 billion in Q1 2026, up 10.51% year-on-year from $1.0 billion in Q1 2025, and down 3.96% quarter-over-quarter from $1.2 billion in Q4 2025.
Boston Scientific (BSX) Construction in Progress (2009 - 2026) Analysis & Trends
Boston Scientific has disclosed Construction in Progress across 18 years of filings, most recently posting $1.1 billion for Q1 2026.
- Construction in Progress for Q1 2026 came in at $1.1 billion, up 10.51% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.1 billion (up 10.51% YoY), and the FY2025 annual result was $1.2 billion, up 12.17% from the prior year.
- Construction in Progress came in at $1.1 billion for Q1 2026 at Boston Scientific, down from $1.2 billion in the prior quarter.
- In the past five years, Construction in Progress ranged from a high of $1.2 billion in Q4 2025 to a low of $513.0 million in Q3 2022.
- The 5-year median for Construction in Progress is $880.0 million (2024), against an average of $820.4 million.
- Across the five-year window, Construction in Progress surged 55.2% in 2024 and dropped 3.11% in 2025, its largest moves.
- Boston Scientific's Construction in Progress stood at $598.0 million in 2022, then soared by 43.31% to $857.0 million in 2023, then increased by 20.77% to $1.0 billion in 2024, then advanced by 12.17% to $1.2 billion in 2025, then slipped by 3.96% to $1.1 billion in 2026.
- The last three Construction in Progress figures came in at $1.1 billion (Q1 2026), $1.2 billion (Q4 2025), and $936.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Construction in Progress (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | - |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | - |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 1.12 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | - |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 509.50 Mn |
| 10 | Zimmer Biomet Holdings | 17.18 Bn | 16.77 Bn | 1.51 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.12 Bn |
| Dec 31, 2025 | 1.16 Bn |
| Sep 30, 2025 | 936.00 Mn |
| Jun 30, 2025 | 1.04 Bn |
| Mar 31, 2025 | 1.01 Bn |
| Dec 31, 2024 | 1.04 Bn |
| Sep 30, 2024 | 966.00 Mn |
| Jun 30, 2024 | 897.00 Mn |
| Mar 31, 2024 | 880.00 Mn |
| Dec 31, 2023 | 857.00 Mn |
| Sep 30, 2023 | 691.00 Mn |
| Jun 30, 2023 | 604.00 Mn |
| Mar 31, 2023 | 567.00 Mn |
| Dec 31, 2022 | 598.00 Mn |
| Sep 30, 2022 | 513.00 Mn |
| Jun 30, 2022 | 537.00 Mn |
| Mar 31, 2022 | 539.00 Mn |
| Dec 31, 2021 | 605.00 Mn |
| Sep 30, 2021 | 465.00 Mn |
| Jun 30, 2021 | 432.00 Mn |